Shandong Lukang Pharmaceutical Co Ltd banner

Shandong Lukang Pharmaceutical Co Ltd
SSE:600789

Watchlist Manager
Shandong Lukang Pharmaceutical Co Ltd Logo
Shandong Lukang Pharmaceutical Co Ltd
SSE:600789
Watchlist
Price: 9.12 CNY Market Closed
Market Cap: ¥9.5B

Net Margin

3%
Current
Declining
by 1.5%
vs 3-y average of 4.6%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
3%
=
Net Income
¥188.8m
/
Revenue
¥6.2B

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
3%
=
Net Income
¥188.8m
/
Revenue
¥6.2B

Peer Comparison

Country Company Market Cap Net
Margin
CN
Shandong Lukang Pharmaceutical Co Ltd
SSE:600789
9.5B CNY
Loading...
US
Eli Lilly and Co
NYSE:LLY
1T USD
Loading...
US
Johnson & Johnson
NYSE:JNJ
591.4B USD
Loading...
CH
Roche Holding AG
SIX:ROG
292.8B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
237.2B GBP
Loading...
CH
Novartis AG
SIX:NOVN
244.9B CHF
Loading...
US
Merck & Co Inc
NYSE:MRK
307.5B USD
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.2T DKK
Loading...
US
Pfizer Inc
NYSE:PFE
153.9B USD
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
122.8B USD
Loading...

Market Distribution

In line with most companies in China
Percentile
48th
Based on 8 721 companies
48th percentile
3%
Low
-416 945.9% — -1.5%
Typical Range
-1.5% — 8.9%
High
8.9% — 17 382.1%
Distribution Statistics
China
Min -416 945.9%
30th Percentile -1.5%
Median 3.5%
70th Percentile 8.9%
Max 17 382.1%

Shandong Lukang Pharmaceutical Co Ltd
Glance View

Market Cap
9.5B CNY
Industry
Pharmaceuticals

In the bustling province of Shandong, a prominent player in the pharmaceutical industry, Shandong Lukang Pharmaceutical Co Ltd, traces its roots back to the mid-20th century, embodying the spirit of innovation in healthcare. This enterprise initially embarked on its journey as a penicillin producer, quickly adapting to the shifts in global healthcare demands by expanding its product line to include a broad spectrum of antibiotics, anti-infectives, and other essential medications. With its headquarters strategically located in Jining, Shandong Lukang leverages sophisticated technology and a rich legacy of expertise to manufacture products that cater to both domestic and international markets. The company's revenue streams are a testament to its diversified approach in the pharmaceutical sector. Primarily, Shandong Lukang excels in the research, development, production, and sale of pharmaceuticals, with antibiotics standing at its core. However, the company has adeptly diversified its operations by venturing into the production of veterinary drugs and biochemical products, creating a robust portfolio that ensures steady growth. By maintaining rigorous quality control and a commitment to innovation, it has positioned itself as a reliable supplier in both public and private healthcare sectors, underpinning its financial success through sustained partnerships and strategic market alliances. This solid foundation ensures that Shandong Lukang remains resilient amid the ever-evolving dynamics of the global pharmaceutical landscape.

Shandong Lukang Pharmaceutical Co Ltd Intrinsic Value
HIDDEN
Show
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
3%
=
Net Income
¥188.8m
/
Revenue
¥6.2B
What is Shandong Lukang Pharmaceutical Co Ltd's current Net Margin?

The current Net Margin for Shandong Lukang Pharmaceutical Co Ltd is 3%, which is below its 3-year median of 4.6%.

How has Net Margin changed over time?

Over the last 3 years, Shandong Lukang Pharmaceutical Co Ltd’s Net Margin has increased from 1.7% to 3%. During this period, it reached a low of 1.7% on Sep 30, 2022 and a high of 6.6% on Jun 30, 2024.

Back to Top